Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 22-Nov-22 4:30 PM View:  | Zhen Marianne Chief Accounting Officer | Theravance Inc. (INVA) | 18-Nov-22 | Payment of Exercise | 828 | $13.55 | $11,219.40 | (2%) 39.48K to 38.65K | |
| 22-Nov-22 4:30 PM View: | Zhen Marianne Chief Accounting Officer | Theravance Inc. (INVA) | 15-Nov-22 | Grant | 433 | -- | -- | 1% 39.05K to 39.48K | |
| 22-Aug-22 6:16 PM View: | Zhen Marianne Chief Accounting Officer | Theravance Inc. (INVA) | 19-Aug-22 | Payment of Exercise | 830 | $14.12 | $11,719.60 | (2%) 39.88K to 39.05K | |
| 23-May-22 4:31 PM View: | Zhen Marianne Chief Accounting Officer | Theravance Inc. (INVA) | 20-May-22 | Payment of Exercise | 828 | $16.29 | $13,488.10 | (2%) 40.71K to 39.88K | |
| 23-May-22 4:31 PM View: | Zhen Marianne Chief Accounting Officer | Theravance Inc. (INVA) | 13-May-22 | Grant | 1,834 | -- | -- | 5% 38.87K to 40.71K | |
| 27-Apr-22 6:52 PM View: | Bickerstaff George Director | Theravance Inc. (INVA) | 25-Apr-22 | Grant | 12,647 | -- | -- | 10% 124.56K to 137.21K | |
| 27-Apr-22 6:47 PM View: | Kostas Odysseas D Director | Theravance Inc. (INVA) | 25-Apr-22 | Grant | 12,647 | -- | -- | 16% 79.56K to 92.21K | |
| 27-Apr-22 6:48 PM View: | Schlesinger Sarah J. Director | Theravance Inc. (INVA) | 25-Apr-22 | Grant | 12,647 | -- | -- | 17% 75.56K to 88.21K | |
| 27-Apr-22 6:51 PM View: | Haimovitz Jules Director | Theravance Inc. (INVA) | 25-Apr-22 | Grant | 12,647 | -- | -- | 14% 87.76K to 100.41K | |
| 27-Apr-22 6:49 PM View: | Dipaolo Mark Director | Theravance Inc. (INVA) | 25-Apr-22 | Grant | 12,647 | -- | -- | 17% 75.56K to 88.21K | |
| 27-Apr-22 6:53 PM View: | Birx Deborah Director | Theravance Inc. (INVA) | 25-Apr-22 | Grant | 12,647 | -- | -- | 42% 29.84K to 42.49K | |
| 02-Mar-22 8:40 PM View: | Zhen Marianne Chief Accounting Officer | Theravance Inc. (INVA) | 01-Mar-22 | Grant | 6,691 | -- | -- | 21% 32.18K to 38.87K | |
| 22-Feb-22 5:06 PM View: | Zhen Marianne Chief Accounting Officer | Theravance Inc. (INVA) | 18-Feb-22 | Payment of Exercise | 2,277 | $19.99 | $45,517.20 | (7%) 34.46K to 32.18K | |
| 22-Nov-21 5:01 PM View: | Zhen Marianne Chief Accounting Officer | Theravance Inc. (INVA) | 19-Nov-21 | Payment of Exercise | 758 | $17.05 | $12,923.90 | (2%) 35.22K to 34.46K | (< 1%) |
| 23-Aug-21 5:02 PM View: | Zhen Marianne Chief Accounting Officer | Theravance Inc. (INVA) | 20-Aug-21 | Payment of Exercise | 760 | $15.94 | $12,114.40 | (2%) 35.36K to 34.6K | 0% |
| 23-Aug-21 5:02 PM View: | Zhen Marianne Chief Accounting Officer | Theravance Inc. (INVA) | 20-Aug-21 | Market Sale | 1,129 | $15.89 | $17,939.80 | 3% 34.23K to 35.36K | < 1% |
| 23-Aug-21 5:02 PM View: | Zhen Marianne Chief Accounting Officer | Theravance Inc. (INVA) | 19-Aug-21 | Market Sale | 2,802 | $16.02 | $44,888.00 | (7%) 39.3K to 36.49K | < 1% |
| 25-May-21 6:44 PM View: | Bickerstaff George Director | Theravance Inc. (INVA) | 24-May-21 | Market Purchase | 10,000 | $13.46 | $134,619.00 | 9% 114.56K to 124.56K | < 1% |
| 25-May-21 6:44 PM View: | Bickerstaff George Director | Theravance Inc. (INVA) | 21-May-21 | Market Purchase | 10,000 | $12.97 | $129,670.00 | 10% 104.56K to 114.56K | 4% |
| 24-May-21 5:19 PM View: | Zhen Marianne Chief Accounting Officer | Theravance Inc. (INVA) | 20-May-21 | Payment of Exercise | 759 | $13.32 | $10,109.90 | (2%) 40.05K to 39.3K | 1% |
| 24-May-21 5:04 PM View: | Glaxosmithkline Plc 10% Owner | Theravance Inc. (INVA) | 20-May-21 | Market Sale | 32,005,300 | $12.25 | $392,064,000.00 | (100%) 32.01M to 0 | (8%) |
| 20-May-21 8:14 PM View: | Dipaolo Mark Director | Theravance Inc. (INVA) | 14-May-21 | Grant | 17,482 | -- | -- | 30% 58.08K to 75.56K | |
| 20-May-21 8:16 PM View: | Bickerstaff George Director | Theravance Inc. (INVA) | 14-May-21 | Grant | 17,482 | -- | -- | 20% 87.08K to 104.56K | |
| 20-May-21 8:13 PM View: | Birx Deborah Director | Theravance Inc. (INVA) | 14-May-21 | Grant | 17,482 | -- | -- | 141% 12.36K to 29.84K | |
| 20-May-21 8:15 PM View: | Kostas Odysseas D Director | Theravance Inc. (INVA) | 14-May-21 | Grant | 17,482 | -- | -- | 28% 62.08K to 79.56K | |
| 20-May-21 8:14 PM View: | Schlesinger Sarah J. Director | Theravance Inc. (INVA) | 14-May-21 | Grant | 17,482 | -- | -- | 30% 58.08K to 75.56K | |
| 20-May-21 8:17 PM View: | Haimovitz Jules Director | Theravance Inc. (INVA) | 14-May-21 | Grant | 17,482 | -- | -- | 25% 70.28K to 87.76K | |
| 30-Mar-21 5:38 PM View: | Birx Deborah Director | Theravance Inc. (INVA) | 29-Mar-21 | Grant | 1,612 | -- | -- | 15% 10.75K to 12.36K | |
| 30-Mar-21 5:41 PM View: | Zhen Marianne Chief Accounting Officer | Theravance Inc. (INVA) | 29-Mar-21 | Grant | 10,305 | -- | -- | 37% 28.09K to 38.4K | |
| 22-Feb-21 7:21 PM View: | Zhen Marianne Chief Accounting Officer | Theravance Inc. (INVA) | 19-Feb-21 | Payment of Exercise | 2,108 | $11.74 | $24,747.90 | (7%) 30.2K to 28.09K | (< 1%) |
| 23-Nov-20 5:04 PM View: | Zhen Marianne Chief Accounting Officer | Theravance Inc. (INVA) | 20-Nov-20 | Payment of Exercise | 798 | $10.95 | $8,738.10 | (3%) 31.0K to 30.2K | (13%) |
| 24-Aug-20 4:15 PM View: | Zhen Marianne Chief Accounting Officer | Theravance Inc. (INVA) | 20-Aug-20 | Payment of Exercise | 797 | $13.19 | $10,512.40 | (3%) 31.04K to 30.24K | 6% |
| 22-May-20 4:15 PM View: | Hulme Geoffrey Interim Principal Exec Officer | Theravance Inc. (INVA) | 20-May-20 | Payment of Exercise | 339 | $14.10 | $4,779.90 | (< 1%) 50.09K to 49.75K | 12% |
| 22-May-20 4:15 PM View: | Zhen Marianne Chief Accounting Officer | Theravance Inc. (INVA) | 20-May-20 | Payment of Exercise | 866 | $14.10 | $12,210.60 | (3%) 31.91K to 31.04K | 12% |
| 28-Apr-20 4:15 PM View: | Bickerstaff George Director | Theravance Inc. (INVA) | 24-Apr-20 | Grant | 16,917 | -- | -- | 24% 70.16K to 87.08K | |
| 28-Apr-20 4:38 PM View: | Kostas Odysseas D Director | Theravance Inc. (INVA) | 24-Apr-20 | Grant | 16,917 | -- | -- | 37% 45.16K to 62.08K | |
| 28-Apr-20 4:09 PM View: | Schlesinger Sarah J. Director | Theravance Inc. (INVA) | 24-Apr-20 | Grant | 16,917 | -- | -- | 41% 41.16K to 58.08K | |
| 28-Apr-20 4:13 PM View: | Haimovitz Jules Director | Theravance Inc. (INVA) | 24-Apr-20 | Grant | 16,917 | -- | -- | 32% 53.37K to 70.28K | |
| 28-Apr-20 4:11 PM View: | Dipaolo Mark Director | Theravance Inc. (INVA) | 24-Apr-20 | Grant | 16,917 | -- | -- | 41% 41.16K to 58.08K | |
| 24-Feb-20 4:40 PM View: | Zhen Marianne Chief Accounting Officer | Theravance Inc. (INVA) | 24-Feb-20 | Market Sale | 2,954 | $14.78 | $43,660.10 | (12%) 24.87K to 21.91K | 17% |
| 24-Feb-20 4:42 PM View: | Hulme Geoffrey Interim Principal Exec Officer | Theravance Inc. (INVA) | 20-Feb-20 | Payment of Exercise | 1,549 | $15.10 | $23,389.90 | (4%) 34.78K to 33.23K | 18% |
| 24-Feb-20 4:40 PM View: | Zhen Marianne Chief Accounting Officer | Theravance Inc. (INVA) | 20-Feb-20 | Payment of Exercise | 2,073 | $15.10 | $31,302.30 | (8%) 26.94K to 24.87K | 18% |
| 21-Nov-19 8:45 PM View: | Zhen Marianne Chief Accounting Officer | Theravance Inc. (INVA) | 20-Nov-19 | Payment of Exercise | 602 | $12.59 | $7,579.18 | (2%) 27.54K to 26.94K | 2% |
| 06-Sep-19 5:00 PM View: | Hulme Geoffrey interim PEO | Theravance Inc. (INVA) | 04-Sep-19 | Grant | 3,000 | $10.89 | $32,684.40 | 10% 31.5K to 34.5K | 13% |
| 21-Aug-19 7:23 PM View: | Zhen Marianne Chief Accounting Officer | Theravance Inc. (INVA) | 20-Aug-19 | Payment of Exercise | 600 | $11.50 | $6,900.00 | (2%) 28.14K to 27.54K | (7%) |
| 23-May-19 9:56 PM View: | Zhen Marianne Chief Accounting Officer | Theravance Inc. (INVA) | 20-May-19 | Payment of Exercise | 601 | $14.21 | $8,540.21 | (2%) 28.74K to 28.14K | 13% |
| 24-May-19 9:58 PM View: | Kostas Odysseas D Director | Theravance Inc. (INVA) | 24-Apr-19 | Grant | 16,399 | -- | -- | 57% 28.76K to 45.16K | |
| 24-May-19 9:58 PM View: | Schlesinger Sarah J. Director | Theravance Inc. (INVA) | 24-Apr-19 | Grant | 16,399 | -- | -- | 66% 24.77K to 41.16K | |
| 24-May-19 9:59 PM View: | Haimovitz Jules Director | Theravance Inc. (INVA) | 24-Apr-19 | Grant | 16,399 | -- | -- | 44% 36.97K to 53.37K | |
| 24-May-19 9:58 PM View: | Dipaolo Mark Director | Theravance Inc. (INVA) | 24-Apr-19 | Grant | 16,399 | -- | -- | 66% 24.77K to 41.16K |
